Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert O. Peckinpaugh"'
Publikováno v:
CRC Critical Reviews in Clinical Laboratory Sciences. 1:451-470
Autor:
Leonard F. Devine, Cline R. Hagerman, Willard E. Pierce, Robert O. Peckinpaugh, David P. Johnson, Solon L. Rhode
Publikováno v:
American Journal of Epidemiology. 93:337-345
Autor:
George Gee Jackson, David P. Johnson, Earl A. Edwards, Frederick B. Askin, Robert O. Peckinpaugh, Willard E. Pierce
Publikováno v:
Annals of the New York Academy of Sciences. 173:62-73
Autor:
Earl A. Edwards, Robert O. Peckinpaugh, Leonard F. Devine, Eugene E. Siess, Solon L. Rhode, Willard E. Pierce, Thomas M. Floyd
Publikováno v:
American Journal of Epidemiology. 92:25-32
Group C meningococcal polysaccharide vaccine was well tolerated by 3, 018 vaccinated Marine recruits. The vaccine appeared to be group-specific since it prevented the acquisition of only group C meningococci. The vaccine stimulated a good hemagglutin
Autor:
Robert O. Peckinpaugh, Willard E. Pierce, Solon L. Rhode, David P. Johnson, Leonard F. Devine, Cline R. Hagerman
Publikováno v:
JAMA. 214(6)
In a double blind study in naval recruits, rifampin reduced the percentage of meningococcal carriers by 80%, compared with controls. It was well tolerated in four daily 600-mg doses. Levels of rifampin in serum samples exceeded the minimal inhibitory
Autor:
Robert O. Peckinpaugh, Max J. Rosenbaum, Earl A. Edwards, George Gee Jackson, Willard E. Pierce
Publikováno v:
JAMA: The Journal of the American Medical Association. 205:5
During an epidemic of acute adenovirus respiratory disease (ARD) in a naval recruit population, mass immunization with an enteric live adenovirus type 4 vaccine resulted in an early dramatic reduction in illness. The decrease of disease in immunized